If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||
![]() EpilepsiaVolume 43 Issue 4, Pages 342 - 349 Published Online: 19 Sep 2008 © 2010 International League Against Epilepsy Published on behalf of the International League Against Epilepsy (ILAE)
Abstract | References | Full Text: HTML, | Related Articles | Citation Tracking Anticonvulsant Actions of Lamotrigine on Spontaneous Thalamocortical Rhythms Copyright 2002 International League Against Epilepsy KEYWORDS Lamotrigine (Lamictal) • Anticonvulsant drug • Whole-cell patch clamp • Generalized absence epilepsy • Generalized tonic–clonic seizure ABSTRACTPurpose: This study examined the actions of lamotrigine (LTG) on epileptiform discharges resembling generalized absence (GA) and primary generalized tonic–clonic (GTC) seizures in rat thalamocortical (TC) brain slices and attempted to characterize further the cellular mechanisms of action of LTG on neuronal ionic conductances. Methods: Rat TC slices generated spontaneous generalized epileptiform discharges after perfusion with a medium containing no added Mg Results: In field-potential recording studies in TC slices, both sTBCs and cTBCs were blocked by clinically relevant concentrations of LTG. In patch-clamp recording studies, LTG was found to be ineffective in the modulation of both GABA Conclusions: The efficacy of LTG on both variants of epileptiform discharges in TC slices clearly parallels its broad human clinical spectrum of action. This demonstrates that neurons within the TC system constitute one probable therapeutic target of LTG. However, LTG did not block either GABAR-mediated responses or I Revision accepted January 16, 2002. |
|